‘Project Salus’ Study 5.6m Vaccinated Medicare Beneficiaries—Waning mRNA Vaccine Effectiveness Raises Questions

‘Project Salus’ Study of 5.6m Vaccinated Medicare Beneficiaries—Waning mRNA Vaccine Effectiveness Raises Questions

Recently, community members sent TrialSite a presentation sponsored by Humetrix, a real-time analytics data platform used to monitor and analyze health care outcomes associated with 5.6 million Medicare beneficiaries (65+). Part of a U.S. Department of Defense study called "Project Salus," or "Effectiveness of mRNA COVID-19 vaccines against the Delta variant among 5.6M Medicare beneficiaries 65 years and older," was recently presented Sept 28, 2021. Consisting of 17, the Project Salus study represented an AI-based project sponsored by the Department of Defense (DoD) and the Joint artificial Intelligence Center (JAIC) to understand better the data associated with the vaccinations. The findings should concern everyone interested in COVID-19 mRNA-based vaccine performance and seriously raise questions about POTUS declarations that the current pandemic is one of the "unvaccinated." If the Project Salus findings are correct—and there are some limitations the authors acknowledge—a majority of those now infected by COVID-19 are vaccinated. This means that transmission may be primarily occurring by vaccinated individuals. A disturbing trend appears starting 3 to 4 months post-vaccina...

Note:  If you need assistance with your subscription or would like to discuss a corporate subscription for more than 10 employees please contact us or use the chat (bottom right).

$5 / Month
Individuals at home that are reading our content for personal health care or other non-professional reasons.
Like a Starbucks a month
Personal - Single Payment
$50 for 1 Year
Individuals - reading for personal reasons who prefer to pay for one year in advance with no recurring billing.
18% discount to monthly
$12 / Month
Professionals from the healthcare industry who are subscribing on behalf of their company for work reasons.
Way better than coffee